Back to search

Article

Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineering

2019-02-15

Abstract excerpt

Hybridoma technology is instrumental for the development of novel antibody therapeutics and diagnostics. Recent preclinical and clinical studies highlight the importance of antibody isotype for therapeutic efficacy. However, since the sequence encoding the constant domains is fixed, tuning antibody function in hybridomas has been restricted. Here, we demonstrate a versatile CRISPR/HDR platform to rapidly engineer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a17dab2c-0f9d-5d32-916f-393c7153539f
DOI
10.1101/551382
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Functional diversification of hybridoma produced antibodies by CRISPR/HDR genomic engineeringDOI 10.1101/551382
Select a neighboring publication to make it the new centre.